The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration ... placebo-controlled and active-controlled. " ...

SINGAPORE – Ketamine, the controlled drug ... be declared a “blockbuster drug” with $1 billion in annual sales. Driving its appeal are its rapid effects and non-invasive procedure, said ...

anxiety, insomnia, nausea, dizziness, tingling, or shock-like sensations. Ask your doctor before you stop. They can help you come up with a schedule to help you wean yourself off the drug with ...

Ben Strahan thought he’d lost the will to live. It had been a long, isolating year for the Reno-based wildland firefighter.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic ... in two randomized controlled trials of acute ...

Cannabis aficionados often emphasize the positive aspects of marijuana and related products, citing a range of generally not ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioid analgesic designed to treat moderate to ...

Even after years of work, courts still have a long way to go: 63% of cases in Superior Courts and Municipal Courts still need ...

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid ... in two randomized controlled trials of ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...